Galapagos Archives -

Lilly, Galapagos suspend trials as COVID-19 hits health systems

https://pharmaphorum.com/news/lilly-galapagos-suspend-trials-as-covid-19-hits-health-systems/

Novartis’ $100m bet on eczema drug fails as MOR106 development ends

https://pharmaphorum.com/news/novartis-100m-bet-on-eczema-drug-fails-as-mor106-development-ends/

Gilead says arthritis drug filgotinib fails in follow-up use trials

https://pharmaphorum.com/news/gilead-says-arthritis-drug-filgotinib-fails-in-follow-up-use-trials/

Gilead invests $5.1bn in Belgian biotech Galapagos

https://pharmaphorum.com/news/gilead-invests-5-1bn-in-belgian-biotech-galapagos/

Galapagos shares surge on RA drug trial results

https://pharmaphorum.com/news/galapagos-shares-surge-drug-trial-results/

Novartis pays up to $1 billion for potential eczema drug

https://pharmaphorum.com/news/novartis-increases-its-immunology-footprint-with-1-billion-deal/

Gilead could make a move for Galapagos within weeks

https://pharmaphorum.com/news/gilead-make-move-galapagos-within-weeks/

Galapagos and FibroGen drugs offer hope in IPF

https://pharmaphorum.com/news/galapagos-fibrogen-ipf/

Search